Implementation of a Mechanical CPR Device in a Physician Staffed HEMS – A Prospective Observational Study
In this prospective, observational study we describe the incidence and characteristics of out of hospital cardiac arrest (OHCA) cases who received mechanical CPR, after the implementation of a mechanical CPR device.
Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization : Fifty Years of Revascularization: Where Are We and Where Are We Heading?
The joint European Society of Cardiology and European Association of Cardio-Thoracic Surgery (ESC/EACTS) guidelines on myocardial revascularization collect and summarize the evidence regarding decision-making, diagnostics, and therapeutics in various clinical scenarios of coronary artery disease, including elective, urgent, and emergency settings.
CABG at 50 (or 107?) — The Complex Course of Therapeutic Innovation
The history of coronary-artery bypass grafting (CABG) demonstrates the subtleties of medical innovation well. Fifty years ago, on May 9, 1967, Cleveland Clinic surgeon René Favaloro performed his first CABG procedure.
Changing the Discussion about On-Pump Versus Off-Pump CABG
The performance of coronary-artery bypass grafting (CABG) without the use of the heart–lung machine (pump) was introduced to avoid the damaging effects of cardiopulmonary bypass.
Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement
We compared long-term mortality and rates of reoperation, stroke, and bleeding between inverse-probability-weighted cohorts of patients who underwent primary aortic-valve replacement or mitral-valve replacement with a mechanical or biologic prosthesis in California in the period from 1996 through 2013.
Ex Vivo Lung Perfusion Review of a Revolutionary Technology
Ex vivo lung perfusion (EVLP) is widely expanding technology to assess and prepare the lungs who are considered marginal for transplantation.
Methylene Blue for Postcardiopulmonary Bypass Vasoplegic Syndrome: A Cohort Study
We sought to determine whether Methylene blue (MB) improved blood pressure in postcardiopulmonary bypass (CPB) vasoplegic syndrome (VS) in a complex cardiac surgery population. Furthermore, to determine variables that predicted response to MB.